Atlas Trials

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

Clinical trial NCT06145308 · RECRUITING

Trial details

NCT number
NCT06145308
Sponsor
Peking Union Medical College
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Salivary Gland CarcinomaPrecision Therapy
Start date
2023-08-15
Primary completion
2028-07-10
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.